Wang, L., Su, N., Zhang, Y., & Wang, G. (2018). Clinical Significance of Serum lncRNA Cancer Susceptibility Candidate 2 (CASC2) for Chronic Renal Failure in Patients with Type 2 Diabetes. Med Sci Monit.
استشهاد بنمط شيكاغوWang, Linxia, Na Su, Yunna Zhang, و Guangya Wang. "Clinical Significance of Serum LncRNA Cancer Susceptibility Candidate 2 (CASC2) for Chronic Renal Failure in Patients With Type 2 Diabetes." Med Sci Monit 2018.
MLA استشهادWang, Linxia, Na Su, Yunna Zhang, و Guangya Wang. "Clinical Significance of Serum LncRNA Cancer Susceptibility Candidate 2 (CASC2) for Chronic Renal Failure in Patients With Type 2 Diabetes." Med Sci Monit 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.